Galectin Therapeutics, Inc. Gains 25.58%

Wed, Jun 01, 2022 at 05:30 PM
Galectin Therapeutics, Inc. Gains 25.58%

Galectin Therapeutics, Inc. (GALT:NASDAQ) shot up at $1.62, representing a gain of 25.6%. On Tue, May 31, 2022, GALT:NASDAQ hit a New 2-Week Intraday High of $1.35. The stock got featured on our News Catalysts scanner on Mon, May 23, 2022 at 09:43 AM in the 'MISCELLANEOUS' category. From Tue, May 17, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Galectin Therapeutics, Inc. (GALT:NASDAQ)

Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.